Skip to main content
Log in

Rituximab as first line treatment for MALT lymphoma of extraocular muscles

  • Letter to the editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, Shin SO, Cho HS, Bae SH, Ryoo HM (2005) Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84:13–18

    Article  PubMed  Google Scholar 

  2. Kimby E (2005) Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31:456–473

    Article  PubMed  CAS  Google Scholar 

  3. Nuckel H, Meller D, Steuhl KP, Duhrsen U (2004) Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 73:258–262

    Article  PubMed  Google Scholar 

  4. Morgensztern D, Rosado MF, Serafini AN, Lossos IS (2004) Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Leuk Lymphoma 45:1275–1278

    Article  PubMed  CAS  Google Scholar 

  5. Asproudis I, Gorezis S, Charonis GC, Tolis C, Tsanou E, Agnantis NJ (2005) Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland—a case report. In Vivo 19:1105–1109

    PubMed  Google Scholar 

  6. Rosado MF, Byrne GE Jr, Ding F, Fields KA, Ruiz P, Dubovy SR, Walker GR, Markoe A, Lossos IS (2006) Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 107:467–472

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonidas Benetatos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benetatos, L., Alymara, V., Asproudis, I. et al. Rituximab as first line treatment for MALT lymphoma of extraocular muscles. Ann Hematol 85, 625–626 (2006). https://doi.org/10.1007/s00277-006-0134-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0134-0

Keywords

Navigation